Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
RESEARCH TOOLSreports
Holding AVTE?
Track your performance easily
See the Price Targets and Ratings of:
AVTE Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AVTE Stock 12 Month Forecast
There Are No Analyst Ratings for AVTE In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
AVTE Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Oppenheimer
$3
Hold
12.15%
Upside
Reiterated
08/13/24
Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (NASDAQ: ORIC), Aerovate Therapeutics (NASDAQ: AVTE) and McKesson (NYSE: MCK)
BTIG
―
Hold
―
Downgraded
06/17/24
Aerovate Therapeutics downgraded to Neutral from Buy at BTIGAerovate Therapeutics downgraded to Neutral from Buy at BTIG
Evercore ISI
$2
Hold
-25.23%
Downside
Downgraded
06/17/24
Aerovate Therapeutics (AVTE) was downgraded to a Hold Rating at Evercore ISI
Guggenheim
―
Hold
―
Downgraded
06/17/24
Aerovate Therapeutics downgraded to Neutral from Buy at Guggenheim
Wells Fargo
$2
Hold
-25.23%
Downside
Downgraded
06/17/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alcon (NYSE: ALC), Aerovate Therapeutics (NASDAQ: AVTE) and Globus Medical (NYSE: GMED)
Jefferies
$65→$2
Hold
-25.23%
Downside
Downgraded
06/17/24
Aerovate Therapeutics downgraded to Hold from Buy at JefferiesAerovate Therapeutics downgraded to Hold from Buy at Jefferies
Wedbush
$41
Buy
1432.71%
Upside
Reiterated
06/06/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) and Aerovate Therapeutics (NASDAQ: AVTE)
Best Analysts Covering Aerovate Therapeutics
Which Analyst Should I Follow If I Want to Buy AVTE and Sell After:
1 Month
xxx
Success Rate
0/2 ratings generated profit
Average Return
-92.00%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -92.00% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
Average Return
-90.45%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -90.45% per trade.
1 Year
Success Rate
0/2 ratings generated profit
Average Return
-86.55%
reiterated a buy rating 6 months ago
Copying Laura Chico's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -86.55% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
Average Return
-86.55%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -86.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AVTE Analyst Recommendation Trends
Rating
Apr 24
May 24
Jun 24
Jul 24
Aug 24
Strong Buy
2
8
7
7
1
Buy
4
5
3
2
0
Hold
0
0
7
8
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
13
17
17
10
Each month's total comprises the sum of three months' worth of ratings.
AVTE Stock Forecast FAQ
What is AVTE’s average 12-month price target, according to analysts?
Currently, no data Available
What is AVTE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AVTE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AVTE a Buy, Sell or Hold?
Currently, no data Available
What is Aerovate Therapeutics’s price target?
Currently, no data Available
What do analysts say about Aerovate Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of AVTE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.